000			01517 a2200397 4500
005			20250515095820.0
264		0	_c20080220
008			200802s 0 0 eng d
022			_a0171-2004
024	7		_a10.1007/978-3-540-74805-2_17 _2doi
040			_aNLM _beng _cNLM
100	1		_aLanger, S Z
245	0	0	_aTherapeutic use of release-modifying drugs. _h[electronic resource]
260			_bHandbook of experimental pharmacology _c2008
300			_a561-73 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAdrenergic alpha-Agonists _xpharmacology
650	0	4	_aAdrenergic alpha-Antagonists _xpharmacology
650	0	4	_aAdrenergic beta-Antagonists _xpharmacology
650	0	4	_aAnimals
650	0	4	_aAntidepressive Agents _xpharmacology
650	0	4	_aAutoreceptors _xdrug effects
650	0	4	_aCannabinoid Receptor Agonists
650	0	4	_aCannabinoid Receptor Antagonists
650	0	4	_aCholinergic Agents _xpharmacology
650	0	4	_aDopamine Agents _xpharmacology
650	0	4	_aHumans
650	0	4	_aNarcotic Antagonists
650	0	4	_aNeurotransmitter Agents _xmetabolism
650	0	4	_aReceptors, Neurotransmitter _xdrug effects
650	0	4	_aReceptors, Opioid _xagonists
650	0	4	_aReceptors, Presynaptic _xdrug effects
650	0	4	_aSerotonin Receptor Agonists _xpharmacology
773	0		_tHandbook of experimental pharmacology _gno. 184 _gp. 561-73
856	4	0	_uhttps://doi.org/10.1007/978-3-540-74805-2_17 _zAvailable from publisher's website
999			_c17578404 _d17578404